Twist is a new prognostic marker for renal survival in patients with chronic kidney disease

American Journal of Nephrology

Volumn 35, Issue 2, 2012, Pages 141-151

  Sun, Shiren ^a   Du, Rui ^a   Xia, Lin ^a   Sun, Wenjuan ^a   Zhai, Ying ^a   Yu, Yan ^a   Zhao, Ali ^a   Huang, Chen ^a   Ning, Xiaoxuan ^a   Wang, Hanmin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hypoxia; Renal fibrosis; Renal survival; Twist

Indexed keywords

CREATININE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR TWIST; UVOMORULIN;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GENE OVEREXPRESSION; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; KIDNEY BIOPSY; KIDNEY PARENCHYMA; KIDNEY TUBULE; KIDNEY TUBULE CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL;

ADULT; ANOXIA; BIOLOGICAL MARKERS; CADHERINS; CELL NUCLEUS; CHRONIC DISEASE; CREATININE; EPITHELIUM; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TWIST TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84862796419     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000335191     Document Type: Article

References (37)

1. Thisse B, Messal M, Perrin-Schmitt F: The Twist gene: Isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res 1987; 15: 3439-3453.
2. Castanon I, Baylies MK: Twist in fate: Evolutionary comparison of Twist structure and function. Genetics 2002; 287: 11-22. (Pubitemid 34460565)
3. Furlong EE, Andersen EC, Null B, et al: Patterns of gene expression during Drosophila mesoderm development. Science 2001; 293: 1629-1633. (Pubitemid 32807836)
4. Yang J, Mani SA, Donaher JL, et al: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-939. (Pubitemid 38798858)
5. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
6. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-142. (Pubitemid 43278296)
7. Acloque H, Thiery JP, Nieto MA: The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep 2008; 9: 322-326.
8. Sun S, Ning X, Zhang Y, et al: Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 2009; 75: 1278-1287.
9. Kida Y, Asahina K, Teraoka H, et al: Twist relates to tubular epithelialmesenchymal transition and interstitial fibrogenesis in the obstructed kidney. J Histochem Cytochem 2007; 55: 661-673. (Pubitemid 46981765)
10. Murea M, Park JK, Sharma S, et al: Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int 2010; 78: 514-522.
11. Higgins DF, Kimura K, Bernhardt WM, et al: Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810-3820. (Pubitemid 350224091)
12. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17.
13. Agarwal A, Nath KA: Effect of proteinuria on renal interstitium: Effect of products of nitrogen metabolism. Am J Nephrol 1993; 13: 376-384. (Pubitemid 24014485)
14. Nangaku M: Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
15. Namikoshi T, Satoh M, Horike H, et al: Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy. Nephron Physiol 2006; 102:p9-p16.
16. Hill GS: Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens 2008; 17: 266-270. (Pubitemid 351535929)
17. Imai T, Horiuchi A, Wang C, et al: Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 2003; 163: 1437-1447. (Pubitemid 37175091)
18. Krishnamachary B, Zagzag D, Nagasawa H, et al: Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 2006; 66: 2725-2731.
19. Evans AJ, Russell RC, Roche O, et al: VHL promotes E 2 box-dependent E-cadherin transcription by HIF mediated regulation of SIP1 and Snail. Mol Cell Biol 2007; 27: 157-169. (Pubitemid 46013241)
20. Erler JT, Bennewith KL, Nicolau M, et al: Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006; 440: 1222-1226.
21. Levine E, Lee CH, Kintner C, et al: Selective disruption of E-cadherin function in early Xenopus embryos by a dominant negative mutant. Development 1994; 120: 901-909. (Pubitemid 24111554)
22. Larue L, Ohsugi M, Hirchenhain J, et al: Ecadherin null mutant embryos fail to form a trophoectoderm epithelium. Proc Natl Acad Sci USA 1994; 9: 8263-8267. (Pubitemid 24253927)
23. Riethmacher D, Brinkmann V, Birchmeier C: A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc Natl Acad Sci USA 1995; 92: 855-859.
24. Brembeck FH, Rosario M, Birchmeier W: Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 2006; 16: 51-59. (Pubitemid 43089612)
25. Cano A, Pérez-Moreno MA, Rodrigo I, et al: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83.
26. Iwano M, Neilson EG: Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 2004; 13: 279-284. (Pubitemid 38582300)
27. Kalluri R, Neilson EG: Epithelialmesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784. (Pubitemid 38063698)
28. Lee TK, Poon RT, Yuen AP, et al: Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006; 12: 5369-5376. (Pubitemid 44497250)
29. Kyo S, Sakaguchi J, Ohno S, et al: High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 2006; 37: 431-438.
30. Zhang Z, Xie D, Li X, et al: Significance of TWIST expression and its association with E-cadherin in bladder cancer. Hum Pathol 2007; 38: 598-606. (Pubitemid 46399887)
31. Sasaki K, Natsugoe S, Ishigami S, et al: Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2009; 28: 158.
32. Menon V, Wang X, Sarnak MJ, et al: Longterm outcomes in nondiabetic chronic kidney disease. Kidney Int 2008; 73: 1310-1315. (Pubitemid 351693160)
33. Ishani A, Grandits GA, Grimm RH, et al: Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the Multiple Risk Factor Intervention Trial. J Am Soc Nephrol 2006; 17: 1444-1452. (Pubitemid 43673426)
34. Peralta CA, Shlipak MG, Judd S, et al: Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011; 305: 1545-1552.
35. Lu X, Kang Y: Hypoxia and hypoxia-inducible factors: Master regulators of metastasis. Clin Cancer Res 2010; 16: 5928-5935.
36. Zeisberg M, Kalluri R: The role of epithelialto-mesenchymal transition in renal fibrosis. J Mol Med 2004; 82: 175-181.
37. Strutz FM: EMT and proteinuria as progression factors. Kidney Int 2009; 75: 475-481.